Company Filing History:
Years Active: 2010
Title: Koc-Kan Hoc: Innovator in Vasopressin V3 Antagonists
Introduction
Koc-Kan Hoc is a notable inventor based in West Windsor, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target specific receptors in the brain. His work focuses on innovations that have the potential to improve treatment options for various mental health conditions.
Latest Patents
Koc-Kan Hoc holds a patent for a compound titled "2-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonists." This invention relates to derivatives of the formula (I) and their application as vasopressin V3 antagonists, specifically aimed at treating depression. This patent highlights his commitment to advancing therapeutic options for mental health disorders.
Career Highlights
Koc-Kan Hoc is associated with N.V. Organon, a company known for its focus on innovative healthcare solutions. His role at the company allows him to collaborate with other talented professionals in the field, contributing to groundbreaking research and development.
Collaborations
Some of Koc-Kan Hoc's coworkers include Jeffrey John Letourneau and Christopher Mark Riviello. Their collective expertise fosters an environment of innovation and creativity, leading to advancements in pharmaceutical research.
Conclusion
Koc-Kan Hoc's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patent for vasopressin V3 antagonists represents a significant step forward in the treatment of depression. Through his career at N.V. Organon, he continues to contribute to the advancement of healthcare solutions.